<DOC>
	<DOCNO>NCT00843284</DOCNO>
	<brief_summary>A Non-Interventional , Post-Marketing Surveillance ( NI-PMS ) study whose objective assess impact pregabalin subject ' pain , quality sleep , general wellbeing , well tolerance safety pregabalin subject neuropathic pain .</brief_summary>
	<brief_title>Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA</brief_title>
	<detailed_description>A non-interventional study patient diagnose neuropathic pain administer pregabalin follow 8 week</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Clinical diagnosis neuropathic pain inclusion accord current Summary Product Characteristics . The patient exclude accord current Summary Product Characteristics .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>neuropathic , pain , pregabalin , Lyrica</keyword>
</DOC>